on 8 Jun 2022
Last Applicant/ Owned by
ALNYLAM PHARMACEUTICALS INC.
675 West Kendall StreetHenri A. Termeer SquareCambridge MA 02142
US
Serial Number
2059189 filed on 4th Sept 2020
Registration Number
TMA1131249 registered on 8th Jun 2022
Registration expiry Date
4th Sept 2030Correspondent Address
PERLEY-ROBERTSON, HILL & MCDOUGALL LLP
1400 - 340 ALBERT STREETOTTAWA
ONTARIO
CA
K1R0A5
Trademark usage description
pharmaceutical preparations for the treatment of amyloidosis.11
2059189
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 26 on 17th Feb 2022 | Approved |
Submitted for opposition 27 on 17th Feb 2022 | Approval Notice Sent |
Submitted for opposition 22 on 11th Feb 2022 | Search Recorded |
Submitted for opposition 256 on 23rd Aug 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 19th Nov 2020 | Agent Changed |
Submitted for opposition 257 on 22nd Oct 2020 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 21st Oct 2020 | Formalized |
Submitted for opposition 1 on 21st Oct 2020 | Created |
Submitted for opposition 228 on 4th Sept 2020 | International Registration |
Submitted for opposition 30 on 4th Sept 2020 | Filed |